SK285338B6 - Farmaceutický prípravok na báze ibuprofénu a spôsob jeho prípravy - Google Patents
Farmaceutický prípravok na báze ibuprofénu a spôsob jeho prípravy Download PDFInfo
- Publication number
- SK285338B6 SK285338B6 SK293-2001A SK2932001A SK285338B6 SK 285338 B6 SK285338 B6 SK 285338B6 SK 2932001 A SK2932001 A SK 2932001A SK 285338 B6 SK285338 B6 SK 285338B6
- Authority
- SK
- Slovakia
- Prior art keywords
- ibuprofen
- cyclodextrin
- mixing
- sodium
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Pain & Pain Management (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200000522A ES2171110B1 (es) | 2000-03-03 | 2000-03-03 | Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK2932001A3 SK2932001A3 (en) | 2001-12-03 |
| SK285338B6 true SK285338B6 (sk) | 2006-11-03 |
Family
ID=8492565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK293-2001A SK285338B6 (sk) | 2000-03-03 | 2001-03-01 | Farmaceutický prípravok na báze ibuprofénu a spôsob jeho prípravy |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1129709B1 (es) |
| AT (1) | ATE298567T1 (es) |
| CZ (1) | CZ301553B6 (es) |
| DE (1) | DE60111657T2 (es) |
| DK (1) | DK1129709T3 (es) |
| ES (1) | ES2171110B1 (es) |
| PT (1) | PT1129709E (es) |
| SK (1) | SK285338B6 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0028575D0 (en) * | 2000-11-23 | 2001-01-10 | Elan Corp Plc | Oral pharmaceutical compositions containing cyclodextrins |
| BRPI0618273A2 (pt) * | 2005-11-02 | 2011-08-23 | Teikoku Pharma Usa Inc | formulações de dosagem oral de ibuprofeno organolepticamente aceitáveis, métodos de produção e uso das mesmas |
| EP1840188B1 (en) | 2006-03-31 | 2011-09-07 | Sony Deutschland GmbH | A composition comprising at least one type of liquid crystal |
| ES2303468B1 (es) * | 2007-01-22 | 2009-06-08 | Masterfarm, S.L | "una composicion farmaceutica pulverulenta que comprende ibuprofeno". |
| EP1974751A1 (en) * | 2007-03-26 | 2008-10-01 | The Jordanian Pharmaceutical Manufacturing Co. | Formulations for non-steroidal anti-inflammatory drugs |
| FR2914187B1 (fr) * | 2007-03-28 | 2011-01-21 | Pf Medicament | Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique. |
| JP5977672B2 (ja) * | 2009-04-27 | 2016-08-24 | ラボラトリオ デ アプリカシオネス ファルマコディナミカス,エセ.アー.Laboratorio De Aplicaciones Farmacodinamicas,S.A. | イブプロフェンリシナートの経口投与用の懸濁液 |
| HUE029953T2 (en) | 2009-04-27 | 2017-04-28 | Laboratorio De Aplicaciones Farm S A | Ibuprofen lysinate oral suspension |
| WO2014194872A1 (en) | 2013-06-04 | 2014-12-11 | Zentiva, K.S. | Taste masking of water soluble drugs using poloxamers |
| AU2024281739A1 (en) | 2023-06-02 | 2025-11-27 | Ioulia Tseti | Pharmaceutical composition comprising ibuprofen |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
| IT1243342B (it) * | 1990-07-13 | 1994-06-10 | Farcon Ag | Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria |
| DE4038314A1 (de) * | 1990-11-30 | 1992-06-04 | Puetter Medice Chem Pharm | Komplexe des aktiven enantiomers des ibuprofens mit cyclodextrin |
| GB9207990D0 (en) * | 1992-04-10 | 1992-05-27 | Smithkline Beecham Plc | Pharmaceutical composition |
| GB9316580D0 (en) * | 1993-08-10 | 1993-09-29 | Smithkline Beecham Plc | Pharmaceutical composition |
| ZA959469B (en) * | 1994-11-15 | 1996-05-15 | South African Druggists Ltd | Pharmaceutical composition |
-
2000
- 2000-03-03 ES ES200000522A patent/ES2171110B1/es not_active Expired - Fee Related
-
2001
- 2001-02-26 CZ CZ20010714A patent/CZ301553B6/cs not_active IP Right Cessation
- 2001-03-01 SK SK293-2001A patent/SK285338B6/sk not_active IP Right Cessation
- 2001-03-01 PT PT01500053T patent/PT1129709E/pt unknown
- 2001-03-01 DE DE60111657T patent/DE60111657T2/de not_active Expired - Lifetime
- 2001-03-01 AT AT01500053T patent/ATE298567T1/de not_active IP Right Cessation
- 2001-03-01 EP EP01500053A patent/EP1129709B1/en not_active Expired - Lifetime
- 2001-03-01 DK DK01500053T patent/DK1129709T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| PT1129709E (pt) | 2005-10-31 |
| CZ2001714A3 (cs) | 2001-10-17 |
| DK1129709T3 (da) | 2005-10-24 |
| ATE298567T1 (de) | 2005-07-15 |
| EP1129709A3 (en) | 2001-11-14 |
| DE60111657D1 (de) | 2005-08-04 |
| EP1129709B1 (en) | 2005-06-29 |
| ES2171110A1 (es) | 2002-08-16 |
| CZ301553B6 (cs) | 2010-04-14 |
| SK2932001A3 (en) | 2001-12-03 |
| DE60111657T2 (de) | 2006-05-04 |
| ES2171110B1 (es) | 2003-06-16 |
| EP1129709A2 (en) | 2001-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69902046T2 (de) | Neue feste dosisform enthaltend nanopartikelnaproxen | |
| JPH02164820A (ja) | イブプロフェン風味マスク法 | |
| DE69520768T2 (de) | Pharmazeutische Zubereitungen, die Fluoxetin enthalten | |
| US5211958A (en) | Pharmaceutical composition and process for its preparation | |
| JP3010562B2 (ja) | 徐放性調剤単位 | |
| JP2003528931A (ja) | 安定な甲状腺ホルモン製剤およびその製法 | |
| US7067154B1 (en) | Pharmaceutical compositions containing Vitamin D and calcium, their preparation and therapeutic use | |
| DE20218068U1 (de) | Arzneimittel | |
| BE1000168A3 (fr) | Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol. | |
| SK285338B6 (sk) | Farmaceutický prípravok na báze ibuprofénu a spôsob jeho prípravy | |
| DE10003757A1 (de) | Ibuprofen-Wirkstoffzubereitung | |
| JP2022031345A (ja) | St-246(テコビリマット一水和物)懸濁製剤 | |
| DE69709349T2 (de) | Arzneimittel bestehend aus diclofenac | |
| CN104254249B (zh) | 帕唑帕尼制剂 | |
| DE60306747T2 (de) | Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion | |
| DE60103276T2 (de) | Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält | |
| JP2008509195A (ja) | ドロスピレノンとエチニルエストラジオールを含有する薬学的組成物 | |
| EP2255810A1 (de) | Arzneiformen mit kontrollierter Bioverfügbarkeit, die Vardenafil enthalten | |
| JP2007131561A (ja) | 経口固形製剤及びその製造法 | |
| EP2726063A1 (en) | Ibuprofen chewable tablet | |
| FI89455B (fi) | Foerfarande foer framstaellning av en farmaceutisk komposition | |
| JP2001294524A (ja) | アセトアミノフェン配合内服固形製剤 | |
| JP2015221806A (ja) | ヒトの血小板レベルを増加させるための組成物および方法 | |
| EP0599767A1 (en) | Process to prepare water-dispersable tablets containing diclofenac | |
| JP3995202B2 (ja) | 経口用ウコン類組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20160301 |